Boyle Scott N - Insider Non-Derivative Transactions at C4 Therapeutics, Inc. (CCCC) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Sep 16, 2024, Boyle Scott N's relationship to C4 Therapeutics, Inc. (CCCC) is Officer (Chief Business Officer), and currently has 54,580 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other CCCC insiders.
Data Source: SEC.
Boyle Scott N - Insider Non-Derivative Transactions of CCCC Common Stock
Boyle Scott N - Insider Non-Derivative Transactions at CCCC
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Sep 17, 2024 | F -- (Common Stock) | 661 | 6.36 | 53919 |
| Sep 17, 2024 | M -- (Common Stock) | 2250 | 0 | 54580 |
| Feb 15, 2024 | Acquisition -- (Common Stock) | 27300 | 0 | 52330 |
| Feb 14, 2024 | F -- (Common Stock) | 1735 | 6.53 | 25030 |
| Aug 31, 2023 | F -- (Common Stock) | 661 | 2.93 | 26765 |
| Aug 31, 2023 | M -- (Common Stock) | 2250 | 0 | 27426 |
| Feb 14, 2023 | Acquisition -- (Common Stock) | 20000 | 0 | 25176 |
| Jan 31, 2023 | F -- (Common Stock) | 1222 | 7.78 | 5176 |
| Jan 31, 2023 | M -- (Common Stock) | 3750 | 0 | 6398 |